STEPS
New Drug Reviews

Benzgalantamine (Zunveyl) for the Treatment of Mild to Moderate Alzheimer Disease

Esther M. Johnston, MD, MPH
Jody L. Lounsbery, PharmD, BCPS

American Family Physician. 2025;112(1):22-23.

Author disclosure: No relevant financial relationships.

ESTHER M. JOHNSTON, MD, MPH, FAAFP, and JODY L. LOUNSBERY, PHARMD, BCPS, University of Minnesota, Minneapolis

Address correspondence to Esther M. Johnston, MD, MPH, FAAFP, at emj@umn.edu.

Author disclosure: No relevant financial relationships.

  1. 1.DailyMed. Drug label information. Zunveyl-benzgalantamine tablet, delayed release. Updated February 18, 2025. Accessed April 17, 2025. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=af47bf67-1f07-4650-8064-24c38afc4656
  2. 2.DailyMed. Drug label information. Galantamine capsule, extended release. Updated January 30, 2024. Accessed April 17, 2025. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d0b75970-8d3d-408b-9e17-9cbad0f776b1
  3. 3.Lim AWY, Schneider L, Loy C. Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment. Cochrane Database Syst Rev. 2024(11):CD001747.
  4. 4.GoodRx. Zunveyl. Accessed April 18, 2025. https://www.goodrx.com/Zunveyl
  5. 5.GoodRx. Galantamine ER. Accessed April 18, 2025. https://www.goodrx.com/Galantamine-ER
  6. 6.GoodRx. Memantine ER. Accessed April 18, 2025. https://www.goodrx.com/memantine-ER

STEPS new drug reviews cover Safety, Tolerability, Effectiveness, Price, and Simplicity. Each independent review is provided by authors who have no financial association with the drug manufacturer.

This series is coordinated by Allen F. Shaughnessy, PharmD, assistant medical editor.

A collection of STEPS published in AFP is available at https://www.aafp.org/afp/steps.

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.